medigraphic.com
SPANISH

Acta Médica Grupo Angeles

Órgano Oficial del Hospital Angeles Health System
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
    • Names and affiliations of the Editorial Board
  • Policies
  • About us
    • Data sharing policy
    • Stated aims and scope
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 2

<< Back Next >>

Acta Med 2023; 21 (2)

Ephedrine versus norepinephrine for maternal hypotension in cesarean section under spinal anesthesia

Albisua AJM, Ortega VF, Carrillo TO, Lazo GR, Pinto SME
Full text How to cite this article 10.35366/110259

DOI

DOI: 10.35366/110259
URL: https://dx.doi.org/10.35366/110259

Language: Spanish
References: 16
Page: 134-139
PDF size: 173.96 Kb.


Key words:

spinal anesthesia, cesarean section, ephedrine, Apgar score, hypotension, norepinephrine.

ABSTRACT

Introduction: subarachnoid spinal block is the form of anesthesia more commonly used for elective cesarean section, though it carries the risk of maternal hemodynamic instability (hypotension or bradycardia). Vasopressors, such as ephedrine in bolus or infused norepinephrine, prevent this adverse event, though the evidence to guide vasopressor choice is insufficient. Objectives: to compare the frequency of hemodynamic instability events in women undergoing elective cesarean section with subarachnoid spinal block treated with ephedrine or norepinephrine. Material and methods: we performed a pragmatic, open-label, non-inferiority, phase IV clinical trial, in which the primary outcomes were the number of bradycardia and hypotension events. We also studied the number of nausea and vomiting events, severe adverse events, and Apgar scores. Results: infused norepinephrine reduced 71% the risk of hypotension, 93% the risk of nausea, and 67% the risk of vomiting. There were no differences in the number of bradycardia events or Apgar scores. Conclusion: norepinephrine is non-inferior to ephedrine to treat maternal hypotension due to subarachnoid spinal block in elective cesarean section.


REFERENCES

  1. Ibarra-López R, Santalla-Piñeiro M, Carabeo-Pujol M, López-Espinosa N, Legón-Carrillo A. Profilaxis de la hipotensión arterial en la cesárea de urgencia. MediCiego. 2017; 23 (3): 12-18.

  2. Montoya-Botero BH, Oliveros-Wilches CI, Moreno-Martínez DA. Manejo de la hipotensión inducida por anestesia espinal para cesárea. Rev Colomb Anestesiol. 2009; 37 (2): 131-140.

  3. Xu S, Mao M, Zhang S, Qian R, Shen X, Shen J et al. A randomized double-blind study comparing prophylactic norepinephrine and ephedrine infusion for preventing maternal spinal hypotension during elective cesarean section under spinal anesthesia: A CONSORT-compliant article. Medicine (Baltimore). 2019; 98 (51): e18311.

  4. Chen D, Qi X, Huang X, Xu Y, Qiu F, Yan Y et al. Efficacy and safety of different norepinephrine regimens for prevention of spinal hypotension in cesarean section: a randomized trial. Biomed Res Int. 2018; 2018: 2708175.

  5. Aragao FF, Aragao PW, Martins CA, Salgado Filho N, Barroqueiro ES. Comparison of metaraminol, phenylephrine and ephedrine in prophylaxis and treatment of hypotension in cesarean section under spinal anesthesia. Rev Bras Anestesiol. 2014; 64 (5): 299-306.

  6. Bolaños-Arboleda D, Fonseca-Ruiz NJ, Socha-García NI, García-Peñuela E, Monsalve-Mejía G. Etilefrina vs. fenilefrina en hipotensión por anestesia espinal para cesárea: ensayo clínico multicéntrico, controlado, aleatorizado y doble ciego. Rev Colomb Anestesiol. 2016; 44 (2): 89-96.

  7. Hasanin AM, Amin SM, Agiza NA, Elsayed MK, Refaat S, Hussein HA et al. Norepinephrine infusion for preventing postspinal anesthesia hypotension during cesarean delivery: a randomized dose-finding trial. Anesthesiology. 2019; 130 (1): 55-62.

  8. Saravanan S, Kocarev M, Wilson RC, Watkins E, Columb MO, Lyons G. Equivalent dose of ephedrine and phenylephrine in the prevention of post-spinal hypotension in Caesarean section. Br J Anaesth. 2006; 96 (1): 95-99.

  9. Miranda D, Lacassie HJ. Fluidoterapia para la prevención de hipotensión arterial secundaria a anestesia espinal en operación cesárea: ¿tenemos todas las respuestas? Rev Chil Anest. 2017; 46 (2): 80-85.

  10. Simon L, Provenchere S, de Saint Blanquat L, Boulay G, Hamza J. Dose of prophylactic intravenous ephedrine during spinal anesthesia for cesarean section. J Clin Anesth. 2001; 13 (5): 366-369.

  11. Onwochei DN, Ngan Kee WD, Fung L, Downey K, Ye XY, Carvalho JCA. Norepinephrine intermittent intravenous boluses to prevent hypotension during spinal anesthesia for cesarean delivery: a sequential allocation dose-finding study. Anesth Analg. 2017; 125 (1): 212-218.

  12. Wang X, Mao M, Liu S, Xu S, Yang J. A comparative study of bolus norepinephrine, phenylephrine, and ephedrine for the treatment of maternal hypotension in parturients with preeclampsia during cesarean delivery under spinal anesthesia. Med Sci Monit. 2019; 25: 1093-1101.

  13. Veeser M, Hofmann T, Roth R, Klohr S, Rossaint R, Heesen M. Vasopressors for the management of hypotension after spinal anesthesia for elective caesarean section. Systematic review and cumulative meta-analysis. Acta Anaesthesiol Scand. 2012; 56 (7): 810-816.

  14. Vallejo MC, Attaallah AF, Elzamzamy OM, Cifarelli DT, Phelps AL, Hobbs GR et al. An open-label randomized controlled clinical trial for comparison of continuous phenylephrine versus norepinephrine infusion in prevention of spinal hypotension during cesarean delivery. Int J Obstet Anesth. 2017; 29: 18-25.

  15. Norma Oficial Mexicana NOM-006-SSA3-2011, Para la práctica de la anestesiología. México: Diario Oficial de la Federación; 2012.

  16. Macarthur A, Riley ET. Obstetric anesthesia controversies: vasopressor choice for postspinal hypotension during cesarean delivery. Int Anesthesiol Clin. 2007; 45 (1): 115-132.




Figure 1
Table 1
Table 2

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Med. 2023;21